Scott Mcfarland, PA
Physician Assistant · Davenport
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Orthopaedic Specialists PC · 15 clinicians in this group
Looking this up.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Scott Mcfarland’s office to ask if they take your plan before you enroll.
Original Medicare doctor bills
$11,447
Medicare paid this office $11,447 for 124 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 22 | $1,870 | $62 |
| Short return visit (20+ min) | 31 | $1,595 | $51 |
| Aspiration and/or injection of fluid from large joint | 24 | $1,301 | $39 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 45 | $1,148 | None |
| X-ray of knee, 3 views | 26 | $660 | $23 |
See all 7 services
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 22 | $1,870 | $62 |
| Short return visit (20+ min) | 31 | $1,595 | $51 |
| Aspiration and/or injection of fluid from large joint | 24 | $1,301 | $39 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 45 | $1,148 | None |
| X-ray of knee, 3 views | 26 | $660 | $23 |
| X-ray of shoulder, minimum of 2 views | 16 | $407 | $21 |
| X-ray of foot, minimum of 3 views | 12 | $210 | $17 |
Procedures Medicare counted
| Upper limb (arm) arthroscopy (minimally invasive joint repair) | 12 | More than 48% of doctors who do this |
Who their Medicare patients are
124 Original Medicare patients in 2024. Average age 74 · Women 56% · Health risk score 1.12. At or below the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 72% · Coronary heart disease 27% · Diabetes 23% · Depression 23% · Chronic kidney disease 20% · COPD 15% · Atrial fibrillation 14% · Cancer 12%.
The office billed $144,486, Medicare allowed $15,264 and paid $11,447; for 522 services of 41 kinds; $2,250 of it was for drugs given in the office and $9,196 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 124 | 522 | 74 | 1.12 | $144,486 | $11,447 |
| 2023 | 194 | 620 | 73 | 1.01 | $837,156 | $23,945 |
| 2022 | 185 | 699 | 72 | 0.96 | $1,091,462 | $29,706 |
| 2021 | 42 | 58 | 74 | 0.70 | $43,387 | $5,920 |
| 2020 | 44 | 80 | 72 | 0.97 | $57,211 | $7,233 |
| 2019 | 50 | 95 | 74 | 0.80 | $61,128 | $7,692 |
| 2018 | 75 | 202 | 74 | 1.05 | $69,437 | $11,502 |
| 2017 | 32 | 54 | 72 | 0.88 | $67,683 | $4,875 |
| 2016 | 19 | 35 | 71 | 0.83 | $32,940 | $2,591 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Replacement of knee joint, both sides of knee | 52 | $6,924 | $126 |
| Replacement of thigh bone and hip joint with prosthesis | 33 | $4,266 | $125 |
| Short return visit (20+ min) | 40 | $2,212 | $47 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 16 | $1,115 | $62 |
| X-ray of knee, 3 views | 37 | $959 | $26 |
| Aspiration and/or injection of fluid from large joint | 19 | $900 | $41 |
| X-ray of hip, 2-3 views | 24 | $679 | $28 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 24 | $149 | None |
2022: 13 services
| Replacement of knee joint, both sides of knee | 54 | $7,461 | $126 |
| Replacement of thigh bone and hip joint with prosthesis | 46 | $6,634 | $128 |
| Revision of thigh and lower leg bone components of total knee joint prosthesis | 13 | $2,257 | $174 |
| New patient visit (45+ min) | 18 | $1,771 | $98 |
| Short return visit (20+ min) | 24 | $1,500 | $58 |
| Aspiration and/or injection of fluid from large joint | 32 | $1,364 | $38 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 18 | $1,229 | $61 |
| X-ray of hip, 2-3 views | 35 | $1,160 | $28 |
| New patient visit (30+ min) | 20 | $1,096 | $55 |
| Return visit (30+ min) | 13 | $1,067 | $76 |
| X-ray of knee, 4 or more views | 31 | $973 | $31 |
| X-ray of knee, 3 views | 21 | $593 | $25 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 40 | $256 | None |
2021: 1 service
| Repair of shoulder rotator cuff using an endoscope | 12 | $1,652 | $138 |
2020: 2 services
| Repair of shoulder rotator cuff using an endoscope | 17 | $2,344 | $138 |
| Removal of extensive shoulder joint tissue using an endoscope | 18 | $487 | $27 |
2019: 2 services
| Repair of shoulder rotator cuff using an endoscope | 28 | $3,733 | $133 |
| Release of tendon connecting biceps muscle and shoulder using an endoscope | 15 | $821 | $55 |
2018: 2 services
| Repair of shoulder rotator cuff using an endoscope | 17 | $2,249 | $132 |
| Short return visit (20+ min) | 27 | $1,553 | $55 |
2017: 1 service
| Repair of shoulder rotator cuff using an endoscope | 12 | $1,583 | $132 |
Medicaid work
$144 in 2022
Medicaid paid $144 for 12 billed services this clinician did in 2022, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 12 | $144 |
| 2022 | 12 | 1 | 12 | $144 |
Drugs they prescribed that Part D paid
$8,211
Pharmacies billed $8,211 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 27% of their Part D prescriptions (209 of 777) in 2024. Above the middle of the specialty; the typical physician assistant clinician is at 1%.
770 generic and fewer than 11 brand-name prescriptions · $8,211 in drug cost · 114 antibiotic prescriptions to 92 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Celecoxib | 72 | $2,580 | $20 |
| Hydrocodone-Acetaminophen | 62 | $1,008 | $13 |
| Gabapentin | 90 | $988 | $8 |
| Oxycodone | 86 | $713 | $7 |
| Ondansetron | 93 | $423 | $4 |
See all 11 drugs
| Celecoxib | 72 | $2,580 | $20 |
| Hydrocodone-Acetaminophen | 62 | $1,008 | $13 |
| Gabapentin | 90 | $988 | $8 |
| Oxycodone | 86 | $713 | $7 |
| Ondansetron | 93 | $423 | $4 |
| Cephalexin | 43 | $226 | $5 |
| Meloxicam | 33 | $158 | $3 |
| Methylprednisolone | 19 | $122 | $6 |
| Tramadol | 20 | $96 | $4 |
| Levofloxacin | 18 | $70 | $4 |
| Amoxicillin | 14 | $17 | $1 |
Year by year
| 2024 | 777 | 232 | 27% (209) | None | $8,211 |
| 2023 | 1,169 | 253 | 34% (400) | 2% | $20,246 |
| 2022 | 1,285 | 197 | 43% (548) | 4% | $41,520 |
| 2021 | 75 | 59 | 92% (69) | None | $813 |
| 2020 | 73 | 48 | 80% (58) | None | $897 |
| 2019 | 167 | 84 | 80% (133) | None | $1,403 |
| 2018 | 109 | 61 | 86% (94) | None | $1,035 |
| 2017 | 93 | 53 | 85% (79) | None | $846 |
| 2016 | 35 | 20 | 91% (32) | 0% | $861 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 11 drugs
| Eliquis | 20 | $11,376 | $569 |
| Meloxicam | 288 | $1,805 | $6 |
| Oxycodone | 182 | $1,532 | $8 |
| Celecoxib | 50 | $1,279 | $26 |
| Ondansetron | 140 | $800 | $6 |
| Cephalexin | 125 | $701 | $6 |
| Hydrocodone-Acetaminophen | 43 | $647 | $15 |
| Tramadol | 174 | $642 | $4 |
| Gabapentin | 39 | $492 | $13 |
| Tamsulosin | 29 | $77 | $3 |
| Folic Acid | 12 | $27 | $2 |
2022: 11 drugs
| Eliquis | 49 | $27,144 | $554 |
| Celecoxib | 92 | $5,889 | $64 |
| Oxycodone | 270 | $2,821 | $10 |
| Ondansetron | 175 | $1,585 | $9 |
| Tramadol | 240 | $890 | $4 |
| Meloxicam | 161 | $836 | $5 |
| Cephalexin | 133 | $769 | $6 |
| Hydrocodone-Acetaminophen | 36 | $435 | $12 |
| Tamsulosin | 47 | $107 | $2 |
| Folic Acid | 24 | $56 | $2 |
| Cyclobenzaprine | 13 | $35 | $3 |
2021: 2 drugs
| Oxycodone-Acetaminophen | 30 | $344 | $11 |
| Hydrocodone-Acetaminophen | 30 | $179 | $6 |
2020: 2 drugs
| Oxycodone-Acetaminophen | 33 | $505 | $15 |
| Hydrocodone-Acetaminophen | 18 | $124 | $7 |
2019: 3 drugs
| Oxycodone-Acetaminophen | 62 | $714 | $12 |
| Hydrocodone-Acetaminophen | 46 | $338 | $7 |
| Tramadol | 17 | $39 | $2 |
2018: 3 drugs
| Oxycodone-Acetaminophen | 40 | $548 | $14 |
| Hydrocodone-Acetaminophen | 31 | $201 | $6 |
| Tramadol | 17 | $36 | $2 |
2017: 2 drugs
| Oxycodone-Acetaminophen | 28 | $356 | $13 |
| Hydrocodone-Acetaminophen | 38 | $296 | $8 |
2016: 1 drug
| Oxycodone-Acetaminophen | 21 | $709 | $34 |
Money from drug and device companies
$841 in 2025
| 2025 | 3 | 33 | None | $841 |
| 2024 | 3 | 25 | None | $822 |
| 2023 | 5 | 17 | None | $572 |
| 2022 | 2 | 5 | None | $77 |
| 2021 | 2 | 2 | None | $151 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Stryker | Blueprint Patient Specific Instrumentation | $640 | 24 payments
|
| Ferring Pharmaceuticals | Euflexxa | $116 | 6 payments
|
| Ethicon US | Dermabond Prineo | $84 | 3 payments
|
See all 33 published payments
| Stryker | Meals · 2025-12-29 | Allofiber | $17 |
| Stryker | Meals · 2025-12-12 | Blueprint Patient Specific Instrumentation | $17 |
| Ferring Pharmaceuticals | Meals · 2025-11-19 | Euflexxa | $19 |
| Ferring Pharmaceuticals | Meals · 2025-10-29 | Euflexxa | $20 |
| Stryker | Meals · 2025-10-27 | Infinity | $13 |
| Stryker | Meals · 2025-10-20 | Blueprint Patient Specific Instrumentation | $46 |
| Stryker | Meals · 2025-09-15 | Augment Injectable | $14 |
| Stryker | Meals · 2025-09-10 | Blueprint Patient Specific Instrumentation | $20 |
| Stryker | Meals · 2025-08-20 | Blueprint Patient Specific Instrumentation | $36 |
| Stryker | Meals · 2025-08-19 | Mako | $103 |
| Ferring Pharmaceuticals | Meals · 2025-08-18 | Euflexxa | $20 |
| Stryker | Meals · 2025-08-14 | Prophecy | $27 |
| Stryker | Meals · 2025-07-16 | Prophecy | $23 |
| Ferring Pharmaceuticals | Meals · 2025-07-09 | Euflexxa | $19 |
| Stryker | Meals · 2025-07-03 | Mako | $9 |
| Stryker | Meals · 2025-06-30 | Prophecy | $24 |
| Ferring Pharmaceuticals | Meals · 2025-06-16 | Euflexxa | $18 |
| Ethicon US | Meals · 2025-06-11 | Dermabond Prineo | $26 |
| Ethicon US | Meals · 2025-05-28 | Dermabond Prineo | $27 |
| Ferring Pharmaceuticals | Meals · 2025-05-12 | Euflexxa | $20 |
| Stryker | Meals · 2025-05-09 | Blueprint Patient Specific Instrumentation | $31 |
| Stryker | Meals · 2025-05-07 | Citrefix | $21 |
| Stryker | Meals · 2025-04-21 | Prostep | $18 |
| Stryker | Meals · 2025-04-14 | T2 Alpha | $31 |
| Stryker | Meals · 2025-03-24 | Prophecy | $12 |
| Stryker | Meals · 2025-03-05 | Prophecy | $16 |
| Stryker | Meals · 2025-02-28 | Blueprint Patient Specific Instrumentation | $50 |
| Stryker | Meals · 2025-01-30 | Prophecy | $23 |
| Stryker | Meals · 2025-01-22 | Blueprint Patient Specific Instrumentation | $12 |
| Stryker | Meals · 2025-01-22 | Blueprint Patient Specific Instrumentation | $30 |
| Stryker | Meals · 2025-01-15 | Simpliciti | $33 |
| Ethicon US | Meals · 2025-01-10 | Dermabond Prineo | $31 |
| Stryker | Meals · 2025-01-06 | Prophecy | $14 |
See earlier years (2024, 2023, 2022, 2021)
2024: $822
| Stryker | Aequalis Flex Revive | $701 | 19 payments
|
| Ferring Pharmaceuticals | Euflexxa | $81 | 5 payments
|
| Ethicon US | Stratafix | $41 | 1 payment
|
2023: $572
| Stryker | Aequalis Flex Revive | $375 | 6 payments
|
| Ferring Pharmaceuticals | Euflexxa | $120 | 8 payments
|
| Ethicon US | Dermabond Prineo | $38 | 1 payment
|
| Pacira Pharmaceuticals | Exparel | $24 | 1 payment
|
| Innovation Technologies | Irrisept | $14 | 1 payment
|
2022: $77
| Ferring Pharmaceuticals | Euflexxa | $62 | 4 payments
|
| Bioventus | Durolane | $15 | 1 payment
|
2021: $151
| NuVasive | Xlif | $125 | 1 payment
|
| Zimmer Biomet Holdings | Relign | $26 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 70.1 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1902252463
- Licence
- CA PA53376
- Trained
- Rush Medical College of Rush University, 2016
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant (363A00000X); Orthopedic surgery (207X00000X)
- Mailing address
- 3385 Dexter Ct Ste 300, Davenport, IA, 52807
- NPI first listed
- 2016-05-13
- NPI last updated
- 2022-04-27
- NPI record certified
- 2021-11-30
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 3803 S Bascom Ave, Campbell, CA, 95008